Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of a chronic urinary tract infection.
Cook JD, Hooey PB, Salazar KC, Clark JR, Jain U, Fernando C, Harvey H, Cervantes A, Omagari S, Blankstein U, Kropinski AM, Davidson AR, Maxwell KL, Burrows LL, Terwilliger AL, Maresso AW, German GJ.
Cook JD, et al.
Int J Antimicrob Agents. 2025 Sep 8;66(6):107613. doi: 10.1016/j.ijantimicag.2025.107613. Online ahead of print.
Int J Antimicrob Agents. 2025.
PMID: 40930191
Free article.